A large healthcare conglomerate long treated as a governance exemplar; book-length critical coverage arrived late and remains sparse.
The US drug industry from patent medicines to the opioid epidemic and the Sacklers.
Johnson & Johnson's record on talc, opioids and Tylenol, reexamined.
Robert Wood Johnson, who put public trust before profit, and the origin of the Credo.
How drug makers became marketing machines, from Risperdal to off-label promotion.
Family history rather than company analysis; gossipy in tone.